Quick Takeaways
- Thomas A. Satterfield Jr. filed SCHEDULE 13G/A for Coherus Oncology, Inc. Common Stock, $0.0001 par value per share (CHRS).
- Disclosed ownership: 4.6%.
- Date of event: 31 Mar 2026.
Thomas A. Satterfield Jr. - 31 Mar 2026 SCHEDULE 13G/A Report for Coherus Oncology, Inc. Common Stock, $0.0001 par value per share (CHRS)
- Filing Manager
- Thomas A. Satterfield Jr.
- Reporting Manager
- Thomas A. Satterfield, Jr.
- Symbol
- CHRS
- Shares outstanding
- 150,652,174 shares
- Disclosed Ownership
- 6,930,000 shares
- Ownership
- 4.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 29 Apr 2026, 21:02:57 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 16 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Thomas A. Satterfield Jr. disclosed 4.6% ownership in Coherus Oncology, Inc. Common Stock, $0.0001 par value per share (CHRS) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 16 Apr 2025.
- Current filing was accepted on 29 Apr 2026, 21:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 4.6% | 6,930,000 | 865,000 | 6,065,000 | /s/ Thomas A. Satterfield, Jr. | Thomas A. Satterfield, Jr. |